Your browser doesn't support javascript.
loading
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.
Gryder, Berkley E; Yohe, Marielle E; Chou, Hsien-Chao; Zhang, Xiaohu; Marques, Joana; Wachtel, Marco; Schaefer, Beat; Sen, Nirmalya; Song, Young; Gualtieri, Alberto; Pomella, Silvia; Rota, Rossella; Cleveland, Abigail; Wen, Xinyu; Sindiri, Sivasish; Wei, Jun S; Barr, Frederic G; Das, Sudipto; Andresson, Thorkell; Guha, Rajarshi; Lal-Nag, Madhu; Ferrer, Marc; Shern, Jack F; Zhao, Keji; Thomas, Craig J; Khan, Javed.
Afiliación
  • Gryder BE; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Yohe ME; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Chou HC; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Zhang X; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Marques J; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Wachtel M; University Children's Hospital, Zurich, Switzerland.
  • Schaefer B; University Children's Hospital, Zurich, Switzerland.
  • Sen N; University Children's Hospital, Zurich, Switzerland.
  • Song Y; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Gualtieri A; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Pomella S; Department of Oncohematology, Ospedale Pediatrico Bambino Gesù Research Institute, Rome, Italy.
  • Rota R; Department of Oncohematology, Ospedale Pediatrico Bambino Gesù Research Institute, Rome, Italy.
  • Cleveland A; Department of Oncohematology, Ospedale Pediatrico Bambino Gesù Research Institute, Rome, Italy.
  • Wen X; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Sindiri S; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Wei JS; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Barr FG; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Das S; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland.
  • Andresson T; Laboratory of Proteomics and Analytical Technologies, Advanced Technologies Center, NCI, Frederick, Maryland.
  • Guha R; Laboratory of Proteomics and Analytical Technologies, Advanced Technologies Center, NCI, Frederick, Maryland.
  • Lal-Nag M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Shern JF; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Zhao K; Genetics Branch, NCI, NIH, Bethesda, Maryland.
  • Thomas CJ; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Khan J; Systems Biology Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Cancer Discov ; 7(8): 884-899, 2017 08.
Article en En | MEDLINE | ID: mdl-28446439
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares / Proteínas de Fusión Oncogénica / Elementos de Facilitación Genéticos / Rabdomiosarcoma Alveolar / Factores de Transcripción Paired Box Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares / Proteínas de Fusión Oncogénica / Elementos de Facilitación Genéticos / Rabdomiosarcoma Alveolar / Factores de Transcripción Paired Box Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article